The Novel Costimulatory Programmed Death Ligand 1/B7.1 Pathway Is Functional in Inhibiting Alloimmune Responses In Vivo
Jun Yang, Leonardo V. Riella, Susanne Chock et al. · The Journal of Immunology · 2011
The programmed death ligand 1 (PDL1)/programmed death 1 (PD1) costimulatory pathway plays an important role in the inhibition of alloimmune responses as well as in the induction and maintenance of peripheral tolerance. It has been demonstrated recently that PDL1 also can bind B7.1 to inhibit T cell responses in vitro. Using the bm12 into B6 heart transplant model, we investigated the functional significance of this interaction in alloimmune responses in vivo. PD1 blockade unlike PDL1 blockade failed to accelerate bm12 allograft rejection, suggesting a role for an additional binding partner for PDL1 other than PD1 in transplant rejection. PDL1 blockade was able to accelerate allograft rejection in B7.2-deficient recipients but not B7.1-deficient recipients, indicating that PDL1 interaction with B7.1 was important in inhibiting rejection. Administration of the novel 2H11 anti-PDL1 mAb, which only blocks the PDL1-B7.1 interaction, aggravated chronic injury of bm12 allografts in B6 recipients. Aggravated chronic injury was associated with an increased frequency of alloreactive IFN-γ-, IL-4-, and IL-6-producing splenocytes and a decreased percentage of regulatory T cells in the recipients. Using an in vitro cell culture assay, blockade of the interaction of PDL1 on dendritic cells with B7.1 on T cells increased IFN-γ production from alloreactive CD4(+) T cells, whereas blockade of dendritic cell B7.1 interaction with T cell PDL1 did not. These data indicate that PDL1 interaction with B7.1 plays an important role in the inhibition of alloimmune responses in vivo and suggests a dominant direction for PDL1 and B7.1 interaction.
Cited by 134 works. doi:10.4049/jimmunol.1100056 Open-access PDF
Authors
- Leonardo V. Riella
- Susanne Chock
- Tao Liu
- Xiaozhi Zhao
- Xueli Yuan
- Alison M. Paterson
- Toshihiko Watanabe
- Vijay K. Vanguri
- Hideo Yagita∥
- Miyuki Azuma
- Bruce R. Blazar
- Gordon James Freeman
- Scott J. Rodig
- Arlene H. Sharpe
- Anil K. Chandraker
- Mohamed H. Sayegh
References
- Engagement of the Pd-1 Immunoinhibitory Receptor by a Novel B7 Family Member Leads to Negative Regulation of Lymphocyte Activation
- PD-1 and Its Ligands in Tolerance and Immunity
- PD-L2 is a second ligand for PD-1 and inhibits T cell activation
- Programmed Death-1 Ligand 1 Interacts Specifically with the B7-1 Costimulatory Molecule to Inhibit T Cell Responses
- B7-Dc, a New Dendritic Cell Molecule with Potent Costimulatory Properties for T Cells
- Blockade of Programmed Death-1 Ligands on Dendritic Cells Enhances T Cell Activation and Cytokine Production
- Tissue expression of PD-L1 mediates peripheral T cell tolerance
- Expression of Programmed Death 1 Ligands by Murine T Cells and APC
- PD-L1 regulates the development, maintenance, and function of induced regulatory T cells
- PRIMARILY VASCULARIZED ALLOGRAFTS OF HEARTS IN MICE